Duragesic (fentanyl) Patches: Drug Safety Communication - Packaging Changes to Minimize Risk of Accidental Exposure
Accidental exposure to fentanyl can cause serious harm and death in children, pets, and others.
Accidental exposure to fentanyl can cause serious harm and death in children, pets, and others.
May result in thrombotic and embolic events, including: pulmonary embolism, myocardial infarction and stroke.
Il Gruppo di coordinamento per il mutuo riconoscimento e le procedure decentrate per i medicinali di uso umano (CMDh), ha adottato all’unanimità la raccomandazione di sospensione dell'autorizzazione all'immissione in commercio di Numeta G13%E e nuove misure di minimizzazione del rischio per Numeta G16%E.
L’Agenzia Italiana del Farmaco in accordo con l’Agenzia Europea dei Medicinali rende disponibile nuove e importanti informazioni su Peginterferone alfa-2b (PegIntron).
May substantially increase blood pressure and/or pulse rate in some patients and presents a risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.
Two separate issues may affect the ability to deliver therapy to a patient in a sudden cardiac arrest event.
One lot of each strength recalled, administration of an injectable with the presence of foreign particulates may potentially cause thrombophlebitis, bacteremia, sepsis, and/or endocarditis and death may result.
Ingestion of DMAA can elevate blood pressure and lead to cardiovascular problems.
Use of a non-sterile injectable product exposes patients to the risk of contracting serious life-threatening infections.
80.211.154.110